Nalaganje...

Alemtuzumab Therapy for Multiple Sclerosis

Alemtuzumab is a humanized monoclonal antibody that is administered daily for 5 days, and then no further therapy is required for 12 months. It causes rapid and prolonged lymphocyte depletion; the consequent homeostatic reconstitution leads to a radically reformed lymphocyte pool with a relative inc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Glavni avtor: Coles, Alasdair J.
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3557360/
https://ncbi.nlm.nih.gov/pubmed/23184314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-012-0159-0
Oznake: Označite
Brez oznak, prvi označite!